Azacitidine, a therapeutic option in Lewis and Sumner syndrome associated with VEXAS syndrome

Elsevier

Available online 8 November 2022

Revue NeurologiqueSection snippetsDisclosure of interest

The authors declare that they have no competing interest.

References (6)I.A. Lambert-Smith et al.The pivotal role of ubiquitin-activating enzyme E1 (UBA1) in neuronal health and neurodegeneration

Int J Biochem Cell Biol

(2020)

D.B. Beck et al.Somatic mutations in UBA1 and severe adult-onset autoinflammatory disease

N Engl J Med

(2020)

P.Y.K. Van den Bergh et al.European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force – second revision

Eur J Neurol

(2021)

There are more references available in the full text version of this article.

View full text

© 2022 Published by Elsevier Masson SAS.

留言 (0)

沒有登入
gif